CLL (Chronic Lymphocytic Leukemia),DLBCL (Diffuse Large B Cell Lymphoma),Leukemia,Lymphoma Epcoritamab Shows Promise in RT: EPCORE CLL-1 Trial Jun 13, 2024
DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma ARG Signature Prognosis & Treatment Promise in DLBCL May 30, 2024
DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma HBsAg Positive Linked to Worse DLBCL Prognosis May 15, 2024
DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma Managing CAR-T Failure: Chidamide & PD-1 Blockade in LBCL May 14, 2024
DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma Optimizing CAR-T Outcomes: Effective Bridging Strategies May 08, 2024
DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma eIF3a in DLBC: Prognostic Biomarker +Therapeutic Target Apr 30, 2024
DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma Enhancing CAR-T Therapy With Nivolumab: Final Analysis Apr 25, 2024
